Skip to content

Vera Therapeutics VERA Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-71.3%-20.6pp-50.7%+22.5pp-73.2%-18.4pp-54.8%-15.3pp-39.5%+5.3pp
Return on assets-59.9%-16.8pp-43.1%+13.8pp-56.9%-12.1pp-44.7%-10.7pp-34.1%+2.5pp
Return on invested capital-77.1%-4.3pp-72.8%+0.7pp-73.5%-18.1pp-55.4%-11.1pp-44.3%+7.2pp
Liquidity
Current ratio13.6×0.0×13.6×+1.4×12.2×-4.8×17×-10.7×27.7×+2.0×
Quick ratio13.6×0.0×13.6×+1.4×12.2×-4.8×17×-10.7×27.7×+2.0×
Cash ratio2.5×-4.1×6.6×+5.3×1.4×-0.1×1.5×-1.1×2.5×-1.1×
Leverage
Debt-to-equity0.2×0.0×0.1×-0.1×0.2×0.0×0.2×+0.1×0.1×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Interest coverage-50.7×-8.8×-41.9×-5.9×-36×-4.5×-31.6×-5.9×-25.7×-3.8×
Per Share
Book value per share$6.99-25.7%$9.41+50.6%$6.25-14.9%$7.34-12.6%$8.40-19.5%
Valuation
Market capitalization$2.87B-20.1%$3.59B+93.8%$1.85B+28.8%$1.44B-6.0%$1.53B-42.8%
Enterprise value$2.83B-14.7%$3.32B+77.0%$1.87B+27.6%$1.47B-4.1%$1.53B-42.0%
Price / book5.7×-0.2×5.9×+1.3×4.6×+1.6×3.1×+0.2×2.9×-1.8×
Free cash flow yield-10.2%-3.5pp-6.7%+4.7pp-11.4%+1.6pp-13%-2.7pp-10.2%-5.1pp
Earnings yield-12.9%-4.5pp-8.3%+5.2pp-13.6%+1.6pp-15.2%-3.7pp-11.5%-5.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Vera Therapeutics's ratios come from?
Every ratio is computed from Vera Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.